Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Nomura Securities Upgrades Beam Inc (BEAM) to Neutral
-
Notable Analyst Rating Changes 01/15: (CMCSA) (INTC) (FTNT) Upgraded; (PETM) (HTZ) (CRUS) Downgraded
-
Nomura Securities Downgrades ENI (E) to Reduce
-
Nomura Securities Starts Scripps Networks Interactive (SNI) at Neutral, $85 PT
-
Nomura Securities Starts AMC Networks (AMCX) at Neutral, $70 PT
-
Nomura Securities Starts Viacom (VIAB) at Neutral, $90 PT
-
Nomura Securities Upgrades Statoil ASA (STO) to Neutral
-
Nomura Securities Starts Time Warner (TWX) at Neutral, $72 PT
-
Nomura Securities Starts Discovery Communications (DISCA) at Buy, $100 PT
-
Nomura Securities Starts 21st Century Fox (FOXA) at Buy, $40 PT
-
Nomura Securities Starts CBS (CBS) at Buy, $75 PT
-
Nomura Securities Starts Walt Disney (DIS) at Buy, $90 PT
-
Nomura Securities Starts AOL, Inc. (AOL) at Neutral, $46 PT
-
Nomura Securities Starts Yahoo! (YHOO) at Neutral
-
Nomura Securities Starts Pandora (P) at Neutral, $35 PT
-
Nomura Securities Starts Netflix (NFLX) at Neutral, $360 PT
-
Nomura Securities Starts Twitter, Inc. (TWTR) at Neutral, $60 PT
-
Nomura Securities Starts TripAdvisor (TRIP) at Buy, $100 PT
-
Nomura Securities Starts Facebook (FB) at Buy, $65 PT
-
Nomura Securities Starts Google (GOOG) at Buy, $1300 PT
-
Discover Financial (DFS) Target Priced Lifted at Nomura
-
Alcoa (AA) Should Trade at Discount, Nomura Says; Estimates Lowered
-
Notable Analyst Rating Changes 01/09: (JCP) (M) (AET) Upgraded; (BWLD) (S) (NVDA) Downgraded
-
Nomura Securities Starts Greenhill (GHL) at Reduce
-
Nomura Securities Starts Charles Schwab Corp. (SCHW) at Neutral, $23 PT
-
Nomura Securities Starts Goldman Sachs (GS) at Neutral
-
Nomura Securities Starts Stifel Financial (SF) at Neutral
-
Nomura Securities Starts Lazard (LAZ) at Neutral
-
Nomura Securities Starts TD Ameritrade (AMTD) at Neutral
-
Nomura Securities Starts JPMorgan (JPM) at Neutral, $61 PT
-
Nomura Securities Starts Morgan Stanley (MS) at Neutral, $34 PT
-
Nomura Securities Starts Evercore Partners (EVR) at Buy, $72 PT
-
Nomura Securities Starts Raymond James (RJF) at Buy, $60 PT
-
Nomura Securities Starts E*TRADE (ETFC) at Buy, $23 PT
-
Nomura Securities Starts LPL Investment (LPLA) at Buy
-
Nomura Securities Starts Bank of America (BAC) at Buy, $19 PT
-
Nomura Securities Starts Citigroup (C) at Buy, $70 PT
-
Notable Analyst Rating Changes 01/08: (RAD) (PNRA) (FLIR) Upgraded; (AMBA) (TWTR) (TCS) Downgraded
-
Mullaly News 'Disappointing' for Microsoft (MSFT): Rick Sherlund
-
Nomura Securities Starts Infinity Pharmaceutical (INFI) at Neutral
-
Nomura Securities Starts Amgen (AMGN) at Neutral, $131 PT
-
Nomura Securities Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral, $75 PT
-
Nomura Securities Starts Synageva BioPharma (GEVA) at Buy, $85 PT
-
Nomura Securities Starts Incyte (INCY) at Buy, $68 PT
-
Nomura Securities Starts Pharmacyclics (PCYC) at Buy
-
Nomura Securities Starts Alexion Pharmaceuticals (ALXN) at Buy, $150 PT
-
Nomura Securities Starts Biogen (BIIB) at Buy, $368 PT
-
Nomura Securities Starts Celgene (CELG) at Buy
-
Nomura Securities Starts Neurocrine Bio. (NBIX) at Buy
-
Nomura Securities Starts Gilead Sciences (GILD) at Buy; Top Biotech Stock Pick for 2014

